Mural Thrombus: Definition, Management, and Clinical Significance
Mural thrombus is a blood clot that forms on the inner wall of a blood vessel or cardiac chamber, extending from the wall into the vessel lumen, potentially causing partial or total occlusion with or without clinical symptoms. 1, 2
Pathophysiology and Locations
Mural thrombi can develop in various cardiovascular locations:
- Cardiac chambers: Most commonly in the left ventricle after anterior myocardial infarction (detected in up to 24% of anterior MI patients by cardiac MRI) 2
- Blood vessels: Can form in arteries (particularly the aorta) or veins, including those with central venous catheters 1
- Catheter-related: Forms around central venous catheters, extending into the vessel lumen 1
The formation mechanism involves:
- Blood stasis (e.g., in areas of wall motion abnormalities after MI)
- Endothelial damage (e.g., from catheter placement or atherosclerosis)
- Hypercoagulability (often in patients with underlying prothrombotic disorders) 2, 3
Clinical Significance and Complications
Mural thrombi pose significant risks:
- Embolization: Fragments can break off and cause distant embolic events
- Vessel occlusion: Can cause partial or complete obstruction of blood flow
- Recurrent thrombosis: DVT recurrence rates of 2-5% 1
- Post-phlebitic syndrome: Incidence range 10-28% with upper extremity venous thrombosis 1
Diagnosis
Detection methods vary by location:
Cardiac mural thrombi:
Vascular mural thrombi:
Management Approaches
Treatment depends on location and clinical context:
For Left Ventricular Thrombus:
- Anticoagulation: Primary treatment with vitamin K antagonists (target INR 2.0-3.0) for approximately 3 months
- Reduces embolism risk by 86%
- Results in thrombus resolution in 68% of cases 2
For Aortic Mural Thrombus:
Anticoagulation: Historically first-line therapy but associated with:
- 25-50% embolic recurrence rate
- Thrombus persistence in 35% of cases
- Need for secondary aortic surgery in up to 31% of cases 3
Surgical intervention: Indicated for:
- Mobile thrombus
- Recurrent embolism
- Contraindication to anticoagulation 3
Endovascular coverage: When feasible, appears effective and safe with low recurrence and re-embolization rates 3
For Catheter-Related Thrombosis:
Anticoagulation: Recommended for a minimum of 3 months
- Low molecular weight heparins (LMWHs) are suggested
- Vitamin K antagonists can also be used 1
Catheter management: The catheter can be kept in place if it is:
- Functional
- Well-positioned
- Non-infected
- Shows good resolution under surveillance 1
Prevention Strategies
For catheter-related thrombosis prevention:
- Proper placement: Right-sided jugular vein insertion with catheter tip at the junction of superior vena cava and right atrium 1
- Catheter selection: Use catheters with minimal necessary lumens (thrombosis risk increases with number of lumens) 1
- Material selection: Less thrombogenic materials (silicone, second/third-generation polyurethane) 1
- Ultrasound guidance: Minimizes endothelial damage during placement 1
Risk Factors for Mural Thrombus Formation
- Anterior MI without reperfusion therapy (approximately one-third risk of apical thrombus) 2
- Severely reduced ejection fraction (<30%) 2
- Anterior MI with apex involvement (24% risk of apical thrombus by cardiac MRI) 2
- Chronic ventricular dysfunction from various etiologies 2
- Transient apical ballooning syndrome 2
- Prothrombotic disorders 3
Recognizing mural thrombus early and implementing appropriate management is crucial for preventing potentially life-threatening complications such as embolization, which can lead to significant morbidity and mortality.